Physician profile
Kathleen Scholz
NPI 1821592643
$396,631.22
in general payments reported to CMS, 2019-2025
11 companies · $131K in 2025
The $131K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $62K · 2023: $60K · 2024: $128K · 2025: $131K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $192K · Travel and Lodging: $89K · Consulting Fee: $24K · Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $192,317.00 |
| Travel and Lodging | $88,733.82 |
| Consulting Fee | $23,778.75 |
| Food and Beverage | $14,248.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $268,466.43 | 2021-2025 | Epclusa, Descovy |
| Abbvie INC. | $127,286.20 | 2021-2025 | |
| Organogenesis INC. | $250.41 | 2023-2025 | Simplimax, Via Matrix, Puraply |
| Mimedx Group, INC. | $153.00 | 2025 | |
| Kerecis Limited | $143.31 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Viiv Healthcare Company | $122.18 | 2023-2024 | Cabenuva, Apretude |
| Biowound Solutions, INC. | $90.97 | 2025 | Bio-Connekt |
| Smith+Nephew, INC. | $56.09 | 2025 | Collagenase Santyl |
| Halozyme INC | $24.46 | 2023 | |
| Antares Pharma, INC. | $20.38 | 2021 | |
| Indivior INC. | $17.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Scholz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.